Skip to main content

Advertisement

Table 4 TDI ecocardiographic parameters of systolic and diastolic function in both arms

From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate

TDI echo t0(n = 49) t2(n = 49) t3(n = 49) t4(n = 49) 12-Month FU (n = 44) 18-Month FU (n = 44)
Em
 PLA 8.66 ± 4.90 8.64 ± 6.07 7.73 ± 4.90 7.54 ± 3.50 7.88 ± 2.07 7.65 ± 1.66
 TEL 7.89 ± 2.14 7.33 ± 2.45 7.53 ± 2.17 6.93 ± 1.46 7.74 ± 1.58 7.49 ± 1.23
Em/Am
 PLA 1.13 ± 0.26 0.85 ± 0.35* 0.72 ± 0.30* 0.75 ± 0.32* 0.96 ± 0.27 0.87 ± 0.33
 TEL 0.90 ± 0.11 0.84 ± 0.07 0.85 ± 0.05 0.71 ± 0.23 0.78 ± 0.28 0.75 ± 0.27
Sm
 PLA 7.15 ± 0.65 7.28 ± 1.71 7.28 ± 0.82 6.83 ± 0.69 7.25 ± 1.37 6.82 ± 0.87
 TEL 7.33 ± 1.76 7.09 ± 1.21 7.04 ± 1.12 7.29 ± 1.08 7.33 ± 1.22 6.61 ± 0.93
Strain (S)
 PLA 20.89 ± 1.96 20.75 ± 2.06 18.00 ± 2.55 18.65 ± 1.25 16.78 ± 2.22 17.78 ± 2.73
 TEL 22.80 ± 1.54 21.20 ± 1.86 20.40 ± 0.94 19.90 ± 0.92 19.64 ± 1.82 19.18 ± 1.70
 TDI echo t0 (n = 49) t2 (n = 49) t3 (n = 49) t4 (n = 49) 12-Month FU (n = 44) 18-Month FU (n = 44)
Em
 PLA 8.66 ± 4.90 8.64 ± 6.07 7.73 ± 4.90 7.54 ± 3.50 7.88 ± 2.07 7.65 ± 1.66
 TEL 7.89 ± 2.14 7.33 ± 2.45 7.53 ± 2.17 6.93 ± 1.46 7.74 ± 1.58 7.49 ± 1.23
Em/Am
 PLA 1.13 ± 0.26 0.85 ± 0.35* 0.72 ± 0.30* 0.75 ± 0.32* 0.96 ± 0.27 0.87 ± 0.33
 TEL 0.90 ± 0.11 0.84 ± 0.07 0.85 ± 0.05 0.71 ± 0.23 0.78 ± 0.28 0.75 ± 0.27
Sm
 PLA 7.15 ± 0.65 7.28 ± 1.71 7.28 ± 0.82 6.83 ± 0.69 7.25 ± 1.37 6.82 ± 0.87
 TEL 7.33 ± 1.76 7.09 ± 1.21 7.04 ± 1.12 7.29 ± 1.08 7.33 ± 1.22 6.61 ± 0.93
Strain (S)
 PLA 20.89 ± 1.96 20.75 ± 2.06 18.00 ± 2.55 18.65 ± 1.25 16.78 ± 2.22 17.78 ± 2.73
 TEL 22.80 ± 1.54 21.20 ± 1.86 20.40 ± 0.94 19.90 ± 0.92 19.64 ± 1.82 19.18 ± 1.70
  1. E m ,TD early diastolic peak velocity; E m /A m ,TD early and late diastolic peak velocity ratio; S m ,TD systolic peak velocity; * p < 0.05 vs t0.